EUVIMEDEUVIMED entdecken
Crossref

Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)

João Marcelino iD, Felix Aulenbacher iD, Helena Pereira iD, Frederico Regateiro iD, Ana Todo-Bom iD, Leonor Leão iD, Diogo Mota iD, Ruben Ferreira iD, Alice Horta iD, Joana Guimarães iD, Elza Tomaz iD, Martin Metz iD

British Journal of Dermatology · 18.08.2026 · 195 (3) · 530-532

DOI: 10.1093/bjd/ljag242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 16.06.2026. Verfasst von João Marcelino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Clinical Allergology Department, Hospital de São Bernardo, Unidade Local de Saúde da Arrábida (ULSA), Setúbal, Portugal. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic spontaneous urticaria (CSU) markedly affects quality of life (QoL), and this study evaluated the Brazilian-Portuguese Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) in 169 patients with CSU, examining its validity, correlations with established patient-reported outcomes, and clinically meaningful severity cutoffs. CU-Q2oL scores correlated strongly with the Dermatology Life Quality Index (DLQI), moderately with the Weekly Urticaria Activity Score (UAS7), and inversely with the Urticaria Control Test (UCT), and a data-driven four-tier severity model showed excellent discriminatory performance. These findings support the CU-Q2oL as a valid QoL instrument in CSU and suggest that the four-tier scoring system may improve clinical stratification and treatment planning.

Autor:innen und Institutionen

  • Immunology and Clinical Allergology Department, Hospital de São Bernardo, Unidade Local de Saúde da Arrábida (ULSA), Setúbal, Portugal.
  • Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • Immunology and Clinical Allergology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
  • Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine, University of Coimbra, Portugal.

ORCID-Profile: João Marcelino, Felix Aulenbacher, Helena Pereira, Frederico Regateiro, Ana Todo-Bom, Leonor Leão, Diogo Mota, Ruben Ferreira, Alice Horta, Joana Guimarães, Elza Tomaz, Martin Metz

Zitieren

APA

Marcelino, J., Aulenbacher, F., Pereira, H., Regateiro, F., Todo-Bom, A., Leão, L., Mota, D., Ferreira, R., Horta, A., Guimarães, J., Tomaz, E., & Metz, M. (2026). Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). British Journal of Dermatology, 195(3), 530-532. https://doi.org/10.1093/bjd/ljag242

Vancouver

Marcelino J, Aulenbacher F, Pereira H, Regateiro F, Todo-Bom A, Leão L, et al. Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). British Journal of Dermatology. 2026;195(3):530-532. doi:10.1093/bjd/ljag242

BibTeX
@article{Marcelino2026,
  author = {Marcelino, João and Aulenbacher, Felix and Pereira, Helena and Regateiro, Frederico and Todo-Bom, Ana and Leão, Leonor and Mota, Diogo and Ferreira, Ruben and Horta, Alice and Guimarães, Joana and Tomaz, Elza and Metz, Martin},
  title = {Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)},
  journal = {British Journal of Dermatology},
  year = {2026},
  volume = {195},
  number = {3},
  pages = {530--532},
  doi = {10.1093/bjd/ljag242}
}
Kostenlos starten →